X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   TEVA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TEVA PHARMA
Dec-13
FDC LTD./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1442,683-   
Low Rs792,330-   
Sales per share (Unadj.) Rs47.61,539.6-  
Earnings per share (Unadj.) Rs7.696.2-  
Cash flow per share (Unadj.) Rs9.0220.6-  
Dividends per share (Unadj.) Rs2.2584.19-  
Dividend yield (eoy) %2.03.4 60.2%  
Book value per share (Unadj.) Rs47.51,710.2-  
Shares outstanding (eoy) m177.83848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.6 143.7%   
Avg P/E ratio x14.626.1 56.1%  
P/CF ratio (eoy) x12.311.4 108.7%  
Price / Book Value ratio x2.31.5 159.7%  
Dividend payout %29.687.5 33.8%   
Avg Mkt Cap Rs m19,7842,125,537 0.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,2210-   
Avg. sales/employee Rs ThNM29,048.4-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,814.6-  
INCOME DATA
Net Sales Rs m8,4591,305,581 0.6%  
Other income Rs m3940-   
Total revenues Rs m8,8521,305,581 0.7%   
Gross profit Rs m2,070357,534 0.6%  
Depreciation Rs m249105,531 0.2%   
Interest Rs m3125,644 0.1%   
Profit before tax Rs m2,184226,359 1.0%   
Minority Interest Rs m01,028 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-148,592 0.0%   
Tax Rs m606-2,764 -21.9%   
Profit after tax Rs m1,35381,559 1.7%  
Gross profit margin %24.527.4 89.4%  
Effective tax rate %27.7-1.2 -2,271.4%   
Net profit margin %16.06.2 256.1%  
BALANCE SHEET DATA
Current assets Rs m4,355881,784 0.5%   
Current liabilities Rs m1,792768,991 0.2%   
Net working cap to sales %30.38.6 350.8%  
Current ratio x2.41.1 212.0%  
Inventory Days Days4491 49.0%  
Debtors Days Days2596 25.7%  
Net fixed assets Rs m3,025426,431 0.7%   
Share capital Rs m1793,214 5.6%   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,4531,450,253 0.6%   
Long term debt Rs m11667,572 0.0%   
Total assets Rs m10,5572,983,670 0.4%  
Interest coverage x71.49.8 726.7%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.80.4 183.1%   
Return on assets %13.13.6 364.9%  
Return on equity %16.05.6 284.6%  
Return on capital %23.54.9 476.7%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,485208,042 0.7%  
From Investments Rs m-620-73,718 0.8%  
From Financial Activity Rs m-753-249,560 0.3%  
Net Cashflow Rs m113-115,236 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 64.27 Rs / USD

Compare FDC LTD. With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare FDC LTD. With: PIRAMAL ENTERPRISES  FULFORD INDIA  CADILA HEALTHCARE  J.B.CHEMICALS  PFIZER  



Today's Market

Sensex Down Around 1%; Telecom & Metal Stocks Decline(01:30 pm)

Indian share markets are trading in the red presently. Sectoral indices are trading in the red with stocks in the telecom sector and metal sector witnessing maximum selling pressure.

Related Views On News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 19, 2018 02:09 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - WYETH LTD COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS